May. 8 at 11:15 PM
$GPCR accumulating more and more in the
$30 range. We might go one last time sub
$34, before blowing up. Buyers are waiting for Roche´s data for their GLP1 drug. If strucutre is still ahead, we will see the buyout at a
$8-10 billion valuation in my opinion